Back to Market Feed

DAPTOMYCIN 350 MG VIAL

daptomycin
$13.4180per EA

Strength

350 mg/7mL

NDC

71839010801

Classification

Generic

Dosage Form

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Route

INTRAVENOUS

Last Updated

7/23/2025

Active Ingredients

DAPTOMYCIN

Approval Type

Generic (ANDA)

FDA Application

ANDA213425

On Market Since

8/20/2020

Pharmacological Classes

Lipopeptide Antibacterial
Lipopeptides

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

+0.4%

3Y

N/A

5Y

N/A

All

-25.2%

Generic Alternatives

1 alternative • Same active ingredient

DAPTOMYCIN 350 MG VIAL
Generic
70594006601•Xellia Pharmaceuticals USA LLC
$13.4180

Related Drugs

Same classification

DAPTOMYCIN 350 MG VIAL
Generic
00409012001•Hospira Inc.
$13.4180
per EA
DAPTOMYCIN 350 MG VIAL
Generic
16729043405•Accord Healthcare Inc.
$13.4180
per EA
DAPTOMYCIN 350 MG VIAL
Generic
25021017915•Sagent Pharmaceuticals
$13.4180
per EA
DAPTOMYCIN 350 MG VIAL
Generic
25021017966•Sagent Pharmaceuticals
$13.4180
per EA
DAPTOMYCIN 350 MG VIAL
Generic
31722021501•Camber Pharmaceuticals Inc.
$13.4180
per EA
DAPTOMYCIN 350 MG VIAL
Generic
43598047611•Dr. Reddy's Laboratories Inc.
$13.4180
per EA
DAPTOMYCIN 350 MG VIAL
Generic
70594005301•Xellia Pharmaceuticals USA LLC
$13.4180
per EA
DAPTOMYCIN 350 MG VIAL
Generic
71288001715•Meitheal Pharmaceuticals Inc.
$13.4180
per EA
DAPTOMYCIN 350 MG VIAL
Generic
71288001791•Meitheal Pharmaceuticals Inc.
$13.4180
per EA
DAPTOMYCIN 350 MG VIAL
Generic
72572010001•Civica, Inc.
$13.4180
per EA